- Coordinator
- European Dynamics Luxembourg SA, Luxembourg
- Runs
- 1 February 2026 to 31 July 2029
- Status
- Running
- EU funding
- €8.9m
- Total cost
- €13.3m
- Partners
- 24 organisations in 10 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101253520
What the project is doing
In the project's own words, from its summary on CORDIS.
Cancer is one of Europe’s leading health burdens, responsible for 26% of all deaths in 2021, with mortality expected to rise by 24% by 2035 and an economic impact exceeding €100 billion annually. Despite the ambitions of Europe’s Beating Cancer Plan, integrating complex cancer data across systems remains a major obstacle. The European Health Data Space (EHDS) seeks to address these gaps, though challenges around interoperability, privacy, and infrastructure persist.
In this context, PATH will transform cancer care by leveraging secure data exchange and digital technologies to improve early detection, diagnosis, treatment, and long-term patient outcomes. Through the integration of AI tools into clinical workflows, PATH will foster a safe, ethical, and sustainable healthcare ecosystem aligned with the Beating Cancer Plan and the EHDS. The project will create a federated, privacy-preserving health data space supporting interoperability and data fairness.
AI models will be trained on representative, FAIR-compliant datasets with built-in transparency and bias mitigation. Federated learning and Trusted Execution Environments will enable secure, real-world model refinement while preserving patient privacy. An AI-powered dashboard will connect clinicians, patients, and developers to deploy validated tools and ensure broad adoption. To ensure long-term impact, PATH will conduct EU-wide pilot studies evaluating clinical outcomes, survivability, efficiency, and cost-effectiveness.
It will also establish scalable business models, promote digital literacy among healthcare professionals, and drive cross-sector collaboration for responsible, evidence-based AI integration across Europe’s cancer care continuum. Delivering this level of clinical, technological, and systemic transformation requires close and sustained collaboration across the entire cancer care and innovation ecosystem. By bringing together the complementary missions, expertise, and capacities of public actors and private companies, the PATH Public–Private Partnership (PPP) composed of 24 partners provides the structural foundation needed to align research excellence, clinical practice, industrial innovation, and policy objectives.
The PPP ensures that PATH solutions are simultaneously scientifically robust, clinically relevant, technologically advanced, and economically sustainable. Moreover, this collaborative framework enhances trust, accelerates knowledge transfer, and supports the translation of innovation from research to real-world healthcare environments—thereby enabling PATH to achieve measurable, scalable, and lasting impact across Europe.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| European Dynamics Luxembourg SA | Luxembourg | Luxembourg | Coordinator |
| Ainigma Technologies | Leuven | Belgium | Participant |
| Hict | Gent | Belgium | Participant |
| Timelex | Bruxelles / Brussel | Belgium | Participant |
| Linac-Pet Scan Opco Limited | Limassol | Cyprus | Participant |
| Pagkyprios Syndesmos Karkinopathon Kai Filon 1986 | Nicosia | Cyprus | Participant |
| Technologiko Panepistimio Kyprou | Lemesos | Cyprus | Participant |
| Aristotelio Panepistimio Thessalonikis | Thessaloniki | Greece | Participant |
| Ethniko Kai Kapodistriako Panepistimio Athinon | Athina | Greece | Participant |
| Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | Thermi Thessaloniki | Greece | Participant |
| European Dynamics Advanced Information Technology and Telecommunication Systems SA | Marousi Athina | Greece | Third party |
| Geniko Nosokomeio Papageorgiou | Thessaloniki | Greece | Participant |
| Idryma Technologias Kai Erevnas | Irakleio | Greece | Participant |
| Panepistimiako Geniko Nosokomeio Irakleiou | Irakleio | Greece | Participant |
| Agora Labs S.r.l. | Collevecchio (Ri) | Italy | Participant |
| Centro Regionale Information E Communication Technology Scrl | Benevento | Italy | Participant |
| Ancora Health BV | Groningen | Netherlands | Participant |
| Fwdfaster Ai Research BV | Utrecht | Netherlands | Participant |
| Universiteit Maastricht | Maastricht | Netherlands | Participant |
| Shine 2europe Lda | Coimbra | Portugal | Participant |
| University of Novi Sad, Faculty of Medicine Novi Sad | Novi Sad | Serbia | Participant |
| Univerzitet U Novom Sadu Fakultet Tehnickih Nauka | Novi Sad | Serbia | Participant |
| Region Sormland | Nykoping | Sweden | Participant |
| Wellics Ltd | London | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI